Home › Funds › Ophir Asset Management Pty Ltd › CDNA
Ophir Asset Management Pty Ltd position in CDNA
CAREDX INC · Health Care
Ophir Asset Management Pty Ltd reported holding 582,406 shares of CDNA (CAREDX INC) in its Q3 2026 13F filing — a position valued at US$37.9M, representing 3.40% of its reported portfolio and ranking #15 among its reported holdings. Ophir Asset Management Pty Ltd has disclosed CDNA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Ophir Asset Management Pty Ltd's CDNA position evolved
Ophir Asset Management Pty Ltd first disclosed a stake in CDNA in Q1 2025 at 1,618,369 shares (US$28.7M). The position peaked in Q3 2026 at 582,406 shares, worth US$37.9M. Across 7 filings, Ophir Asset Management Pty Ltd increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 582,406 shares valued at US$37.9M — a reduction of -682,403 shares quarter over quarter.. Notable position changes include a 58% trim in Q4 2025 (shares fell 8% over the following quarter), a 28% increase in Q2 2026 (shares rose 128% over the following quarter), a 54% trim in Q3 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 1.62M | $28.73M | New |
| Q2 2025 | 1.89M | $24.34M | Add |
| Q3 2025 | 2.20M | $31.96M | Add |
| Q4 2025 | 925.43K | $17.44M | Reduce |
| Q1 2026 | 988.05K | $17.15M | Add |
| Q2 2026 | 1.26M | $36.05M | Add |
| Q3 2026 | 582.41K | $37.86M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CDNA and 13F data
CDNA (CAREDX INC) is a Health Care company. 50 other funds we track also report a position in CDNA — the largest reported positions include Blue Water Life Science Advisors, LP (US$113.1M), ARK Invest (US$104.6M), GAGNON SECURITIES LLC (US$69.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CDNA
- Blue Water Life Science Advisors, LP 1.74M sh · $113.10M · Q3 2026
- ARK Invest 1.61M sh · $104.59M · Q3 2026
- GAGNON SECURITIES LLC 1.07M sh · $69.84M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.00M sh · $56.93M · Q2 2026
- Amova Asset Management Americas, Inc. 625.42K sh · $40.63M · Q3 2026
- BRAIDWELL LP 1.22M sh · $34.79M · Q2 2026
- Zweig-DiMenna Associates LLC 389.81K sh · $25.34M · Q3 2026
- Divisadero Street Capital Management, LP 700.94K sh · $19.98M · Q2 2026
- Portolan Capital Management, LLC 684.80K sh · $19.52M · Q2 2026
- Gagnon Advisors, LLC 286.89K sh · $18.65M · Q3 2026
- Palo Alto Investors LP 531.87K sh · $15.16M · Q2 2026
More on Ophir Asset Management Pty Ltd
FAQ
How long has Ophir Asset Management Pty Ltd held CDNA?
Ophir Asset Management Pty Ltd has disclosed CDNA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Ophir Asset Management Pty Ltd's current position in CDNA?
As of Q3 2026, Ophir Asset Management Pty Ltd holds 582.41K shares of CDNA (CAREDX INC), valued at $37.86M, representing 3.40% of its reported portfolio and ranking #15.
Has Ophir Asset Management Pty Ltd been buying or selling CDNA?
In the latest 13F filing (Q3 2026), Ophir Asset Management Pty Ltd reduced its position in CDNA. The position peaked in Q3 2026 at 582.41K shares.
Which other funds hold CDNA?
Other major institutional holders of CDNA include Blue Water Life Science Advisors, LP, ARK Invest, GAGNON SECURITIES LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.